Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shuxuening Injection for Prevention of Cerebral Vasospasm in aSAH
NCT06138353Phase 3Recruiting
- Start
- Jan 2024
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ginkgo biloba leaf extract injection in aneurysmal subarachnoid hemorrhage (SAH). Started Jan 2024; status: recruiting.
02
Drugs
ginkgo biloba leaf extract injection
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT06138353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06138353.